[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Proteome Sciences Plc (PRM) - Financial and Strategic SWOT Analysis Review

July 2021 | 41 pages | ID: P48779E2769EN
GlobalData

US$ 125.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Proteome Sciences Plc (PRM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Proteome Sciences Plc (Proteome Sciences) is a life sciences company that delivers content for personalized medicine through biomarkers, reagents and services. Its proteomics services include drug development, biomarker discovery, quality management and provision of data insights. The company detects and characterizes deferentially expressed proteins using its proprietary technologies in biological samples for prognostic, diagnostic and therapeutic applications. The company offers its services to pharmaceutical and biotechnology companies and academic research institution. It has a research facility in Frankfurt, Germany and operates in the US, Germany and the UK. Proteome Sciences is headquartered in London, England, the UK.

Proteome Sciences Plc Key Recent Developments

May 19,2021: Proteome Sciences announces issuance of key TMT patent and introduction of 18plex TMTpro services
May 18,2021: Proteome Sciences: Change of registered office
Apr 01,2021: Proteome Sciences: Final results for the year ended 31 December 2020
Mar 30,2021: Proteome Sciences: Loan amendment
Sep 14,2020: Proteome Sciences announces appointment of Chief Executive Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Proteome Sciences Plc - Key Facts
Proteome Sciences Plc - Key Employees
Proteome Sciences Plc - Key Employee Biographies
Proteome Sciences Plc - Major Products and Services
Proteome Sciences Plc - History
Proteome Sciences Plc - Company Statement
Proteome Sciences Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Proteome Sciences Plc - Business Description
Product Category: Biomarker services and other license income
Performance
Product Category: TMT Royalties
Performance
Product Category: TMT Sales
Performance
Product Category: Grant Income
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Rest of the World
Performance
Geographical Segment: The United Kingdom
Performance
Geographical Segment: The United States
Performance
R&D Overview
Proteome Sciences Plc - Corporate Strategy
Proteome Sciences Plc - SWOT Analysis
SWOT Analysis - Overview
Proteome Sciences Plc - Strengths
Proteome Sciences Plc - Weaknesses
Proteome Sciences Plc - Opportunities
Proteome Sciences Plc - Threats
Proteome Sciences Plc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Proteome Sciences Plc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 19, 2021: Proteome Sciences announces issuance of key TMT patent and introduction of 18plex TMTpro services
May 18, 2021: Proteome Sciences: Change of registered office
Sep 14, 2020: Proteome Sciences announces appointment of Chief Executive Officer
Jan 21, 2020: Proteome Sciences : Year end trading update

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Proteome Sciences Plc, Key Facts
Proteome Sciences Plc, Key Employees
Proteome Sciences Plc, Key Employee Biographies
Proteome Sciences Plc, Major Products and Services
Proteome Sciences Plc, History
Proteome Sciences Plc, Other Locations
Proteome Sciences Plc, Subsidiaries
Proteome Sciences Plc, Key Competitors
Proteome Sciences Plc, Ratios based on current share price
Proteome Sciences Plc, Annual Ratios
Proteome Sciences Plc, Annual Ratios (Cont...1)
Proteome Sciences Plc, Interim Ratios
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Proteome Sciences Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Proteome Sciences Plc, Performance Chart (2016 - 2020)
Proteome Sciences Plc, Ratio Charts
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021


More Publications